Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiu-Feng Huang

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 29, 2008
Increased epidermal growth factor receptor (EGFR) gene copy number is strongly associated with EGFR mutations and adenocarcinoma in non-small cell lung cancers: a chromogenic in situ hybridization study of 182 patientsJohn Wen-Cheng Chang, Hui-Ping Liu, Meng-Heng Hsieh, et al.
The New England Journal of Medicine|June 3, 2005
Type II collagen gene variants and inherited osteonecrosis of the femoral headYu-Fen Liu, Wei-Ming Chen, Yung-Feng Lin, et al.
Annals of Hepatology|August 7, 2025
Secular trends and survival impact of high proportion of curative treatments for hepatocellular carcinoma in Taiwan, 2011-2019Kwong-Ming Kee, Chien-Hung Chen, Tsang-Wu Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2007
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinibJames Bean, Cameron Brennan, Jin-Yuan Shih, et al.
International Journal of Hepatology|May 22, 2013
Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological ClassificationCharles Balabaud, Wesal R Al-Rabih, Pei-Jer Chen, et al.
Analytical Biochemistry|March 25, 2008
A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitorsWen-Hsing Lin, Jen-Shin Song, Teng-Yuan Chang, et al.
Anticancer Research|March 9, 2012
Erlotinib treatment in patients with advanced lung adenocarcinoma with CISH-positive and CISH-negative EGFR gene alterationsMing-Mo Hou, Shiu-Feng Huang, Han-Pin Kuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2010
Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicityShih Sheng Jiang, Wen-Tsen Fang, Ya-Hsiue Hou, et al.
Viruses|January 21, 2023
Secular Trends of Clinical Characteristics and Survival of Hepatocellular Carcinoma in Taiwan from 2011 to 2019Kwong-Ming Kee, Chien-Hung Chen, Jui-Ting Hu, et al.
Hepatology International|August 13, 2021
First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patientsJee-Fu Huang, Chia-Yen Dai, Chung-Feng Huang, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
Lung Cancer (Amsterdam, Netherlands)|February 29, 2008
Increased epidermal growth factor receptor (EGFR) gene copy number is strongly associated with EGFR mutations and adenocarcinoma in non-small cell lung cancers: a chromogenic in situ hybridization study of 182 patientsJohn Wen-Cheng Chang, Hui-Ping Liu, Meng-Heng Hsieh, et al.
The New England Journal of Medicine|June 3, 2005
Type II collagen gene variants and inherited osteonecrosis of the femoral headYu-Fen Liu, Wei-Ming Chen, Yung-Feng Lin, et al.
Annals of Hepatology|August 7, 2025
Secular trends and survival impact of high proportion of curative treatments for hepatocellular carcinoma in Taiwan, 2011-2019Kwong-Ming Kee, Chien-Hung Chen, Tsang-Wu Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2007
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinibJames Bean, Cameron Brennan, Jin-Yuan Shih, et al.
International Journal of Hepatology|May 22, 2013
Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological ClassificationCharles Balabaud, Wesal R Al-Rabih, Pei-Jer Chen, et al.
Analytical Biochemistry|March 25, 2008
A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitorsWen-Hsing Lin, Jen-Shin Song, Teng-Yuan Chang, et al.
Anticancer Research|March 9, 2012
Erlotinib treatment in patients with advanced lung adenocarcinoma with CISH-positive and CISH-negative EGFR gene alterationsMing-Mo Hou, Shiu-Feng Huang, Han-Pin Kuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2010
Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicityShih Sheng Jiang, Wen-Tsen Fang, Ya-Hsiue Hou, et al.
Viruses|January 21, 2023
Secular Trends of Clinical Characteristics and Survival of Hepatocellular Carcinoma in Taiwan from 2011 to 2019Kwong-Ming Kee, Chien-Hung Chen, Jui-Ting Hu, et al.
Hepatology International|August 13, 2021
First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patientsJee-Fu Huang, Chia-Yen Dai, Chung-Feng Huang, et al.
Pageof 15